Novavax Inc

A biotechnology company Novavax Inc (NASDAQ:NVAX) is into the production of next-generation vaccines for the treatment of serious infectious diseases. The Company has discovered a vaccine candidate for COVID-19 named as NVX-CoV2373 which is a stable, prefusion protein produced by employing the proprietary nanoparticle-based technology of Novavax.

Similar Companies